Menu
Back to Journals » Drug Design, Development and Therapy » Volume 9
Review
Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 68,585 | Dovepress* | 40,863+ | 4,197 | 45,060 | |
| PubMed Central* | 27,722 | 5,758 | 33,480 | ||
| Totals | 68,585 | 9,955 | 78,540 | ||
|
*Since 10 August 2015 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 16 | 0 | 0 | 0 | 1 | 15 |
View citations on PubMed Central and Google Scholar